let's begin--Arthritis Today reports a clinical trial phase 111 on a
promising new....ORAL...drug for RA.

TOFACITIMAB is the first oral medication that may have an efficacy
similar to injectable biologics. If FDA approved, it will be the first
pill in nearly ten years for RA.

It is a Janus kinase (jak) inhibitor, which blocks a type of protein
that causes inflammation.

For those averse to needles, or those who have reacted badly to
injectables, a hope for the future.